Skip to main content Back to Top
Advertisement

10/9/2019

Midodrine Tablets

Products Affected - Description

    • Midodrine tablets oral tablet, Amneal, 2.5 mg, 100 count, NDC 00115-4211-01 - discontinued
    • Midodrine tablets oral tablet, Sandoz, 10 mg, 100 count, NDC 00185-0149-01 - discontinued
    • Midodrine tablets oral tablet, Sandoz, 2.5 mg, 100 count, NDC 00185-0040-01 - discontinued
    • Midodrine tablets oral tablet, Sandoz, 5 mg, 100 count, NDC 00185-0043-01 - discontinued
    • Midodrine tablets oral tablet, Sandoz, 5 mg, 500 count, NDC 00185-0043-05 - discontinued

Reason for the Shortage

    • Apotex has midodrine tablets available.
    • Impax discontinued midodrine tablets in July 2018.
    • Mylan has midodrine 5 mg tablets available.
    • Sandoz discontinued midodrine tablets in mid-2018.
    • Upsher-Smith has midodrine tablets available.

Available Products

    • Midodrine tablets oral tablet, Apotex, 10 mg, 100 count, NDC 60505-1325-01
    • Midodrine tablets oral tablet, Apotex, 2.5 mg, 100 count, NDC 60505-1320-01
    • Midodrine tablets oral tablet, Apotex, 5 mg, 100 count, NDC 60505-1321-01
    • Midodrine tablets oral tablet, Mylan, 5 mg, 100 count, NDC 51079-0453-20
    • Midodrine tablets oral tablet, Upsher-Smith, 10 mg, 100 count, NDC 00245-0213-11
    • Midodrine tablets oral tablet, Upsher-Smith, 2.5 mg, 100 count, NDC 00245-0211-11
    • Midodrine tablets oral tablet, Upsher-Smith, 5 mg, 100 count, NDC 00245-0212-11

Updated

Updated October 9, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 13, 2018 by Anthony Trovato, PharmD, BCPS. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins